Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1987 Dec;40(12):1424–1427. doi: 10.1136/jcp.40.12.1424

Immunocytological staining reactions of anti-carcinoembryonic antigen, Ca, and anti-human milk fat globule monoclonal antibodies on benign and malignant exfoliated mesothelial cells.

A K Ghosh 1, E B Butler 1
PMCID: PMC1141277  PMID: 3323250

Abstract

A panel of three monoclonal antibodies were used in an immunoalkaline phosphatase staining method on a series of serous effusion samples from cases of mesothelioma, lung carcinoma, and benign disease. The antibodies used were anti-carcinoembryonic (CEA) antigen, Ca, and anti-human milk fat globule membrane antigen. Antibodies to the Ca antigen and human milk fat globule membrane antigen stained 75% and 83% of mesothelioma and 75% of cases of lung carcinoma, respectively. The anti-CEA antibody stained most cases of lung carcinoma strongly but was negative on 11 of 12 cases of mesothelioma and showed weak staining on one case. Benign cases were negative with all three antibodies. These three antibodies may be useful in distinguishing benign and malignant mesothelial cells and lung carcinoma in serous effusions.

Full text

PDF
1424

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashall F., Bramwell M. E., Harris H. A new marker for human cancer cells. 1 The Ca antigen and the Ca1 antibody. Lancet. 1982 Jul 3;2(8288):1–6. doi: 10.1016/s0140-6736(82)91150-3. [DOI] [PubMed] [Google Scholar]
  2. Bramwell M. E., Ghosh A. K., Smith W. D., Wiseman G., Spriggs A. I., Harris H. Ca2 and Ca3. New monoclonal antibodies evaluated as tumor markers in serous effusions. Cancer. 1985 Jul 1;56(1):105–110. doi: 10.1002/1097-0142(19850701)56:1<105::aid-cncr2820560117>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  3. Butler E. B., Johnson N. F. The use of electron microscopy in the diagnosis of diffuse mesotheliomas using human pleural effusions. IARC Sci Publ. 1980;(30):409–418. [PubMed] [Google Scholar]
  4. Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., MacDonald S., Pulford K. A., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984 Feb;32(2):219–229. doi: 10.1177/32.2.6198355. [DOI] [PubMed] [Google Scholar]
  5. Cordell J., Richardson T. C., Pulford K. A., Ghosh A. K., Gatter K. C., Heyderman E., Mason D. Y. Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer. 1985 Sep;52(3):347–354. doi: 10.1038/bjc.1985.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Corson J. M., Pinkus G. S. Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas. Am J Pathol. 1982 Jul;108(1):80–88. [PMC free article] [PubMed] [Google Scholar]
  7. Gatter K. C., Abdulaziz Z., Beverley P., Corvalan J. R., Ford C., Lane E. B., Mota M., Nash J. R., Pulford K., Stein H. Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol. 1982 Nov;35(11):1253–1267. doi: 10.1136/jcp.35.11.1253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gatter K. C., Dunnill M. S., Pulford K. A., Heryet A., Mason D. Y. Human lung tumours: a correlation of antigenic profile with histological type. Histopathology. 1985 Aug;9(8):805–823. doi: 10.1111/j.1365-2559.1985.tb02868.x. [DOI] [PubMed] [Google Scholar]
  9. Ghosh A. K., Gatter K. C., Dunnill M. S., Mason D. Y. Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies. J Clin Pathol. 1987 Jan;40(1):19–25. doi: 10.1136/jcp.40.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Harkness R. A., Lund R. J. Cerebrospinal fluid concentrations of hypoxanthine, xanthine, uridine and inosine: high concentrations of the ATP metabolite, hypoxanthine, after hypoxia. J Clin Pathol. 1983 Jan;36(1):1–8. doi: 10.1136/jcp.36.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Harkness R. A., Lund R. J. Cerebrospinal fluid concentrations of hypoxanthine, xanthine, uridine and inosine: high concentrations of the ATP metabolite, hypoxanthine, after hypoxia. J Clin Pathol. 1983 Jan;36(1):1–8. doi: 10.1136/jcp.36.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kwee W. S., Veldhuizen R. W., Alons C. A., Morawetz F., Boon M. E. Quantitative and qualitative differences between benign and malignant mesothelial cells in pleural fluid. Acta Cytol. 1982 Jul-Aug;26(4):401–406. [PubMed] [Google Scholar]
  13. Loosli H., Hurlimann J. Immunohistological study of malignant diffuse mesotheliomas of the pleura. Histopathology. 1984 Sep;8(5):793–803. doi: 10.1111/j.1365-2559.1984.tb02395.x. [DOI] [PubMed] [Google Scholar]
  14. Marshall R. J., Herbert A., Braye S. G., Jones D. B. Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium. J Clin Pathol. 1984 Nov;37(11):1215–1221. doi: 10.1136/jcp.37.11.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. NAYLOR B. THE EXFOLIATIVE CYTOLOGY OF DIFFUSE MALIGNANT MESOTHELIOMA. J Pathol Bacteriol. 1963 Oct;86:293–298. doi: 10.1002/path.1700860204. [DOI] [PubMed] [Google Scholar]
  16. Singer S., Boddington M. M., Hudson E. A. Immunocytochemical reaction of Ca1 and HMFG2 monoclonal antibodies with cells from serous effusions. J Clin Pathol. 1985 Feb;38(2):180–184. doi: 10.1136/jcp.38.2.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Taylor-Papadimitriou J., Peterson J. A., Arklie J., Burchell J., Ceriani R. L., Bodmer W. F. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer. 1981 Jul 15;28(1):17–21. doi: 10.1002/ijc.2910280104. [DOI] [PubMed] [Google Scholar]
  18. To A., Dearnaley D. P., Ormerod M. G., Canti G., Coleman D. V. Epithelial Membrane Antigen. Its use in the cytodiagnosis of malignancy in serous effusions. Am J Clin Pathol. 1982 Aug;78(2):214–219. doi: 10.1093/ajcp/78.2.214. [DOI] [PubMed] [Google Scholar]
  19. Walts A. E., Said J. W., Banks-Schlegel S. Keratin and carcinoembryonic antigen in exfoliated mesothelial and malignant cells: an immunoperoxidase study. Am J Clin Pathol. 1983 Nov;80(5):671–676. doi: 10.1093/ajcp/80.5.671. [DOI] [PubMed] [Google Scholar]
  20. Wang N. S., Huang S. N., Gold P. Absence of carcinoembryonic antigen-like material in mesothelioma: an immunohistochemical differentiation from other lung cancers. Cancer. 1979 Sep;44(3):937–943. doi: 10.1002/1097-0142(197909)44:3<937::aid-cncr2820440322>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES